Literature DB >> 19656479

The relationship of intranasal steroids to intraocular pressure.

Joseph Bergmann1, Matthew T Witmer, Charles B Slonim.   

Abstract

Intranasal corticosteroids have become a gold standard in therapy for allergic rhinoconjunctivitis. A direct relationship between topical and systemic corticosteroids and elevated intraocular pressure (IOP) has been recognized for more than 50 years. However, this steroid-induced response is highly variable. Glaucoma is an eye disease caused by an increase in IOP and results in optic nerve cell death and vision loss. Intranasal corticosteroids are absorbed systemically albeit in small measurable amounts. Some studies suggest a relationship between intranasal steroids and increased IOP. Large prospective studies to determine if there is a significant relationship between intranasal steroids and increased IOP are lacking. We review the current knowledge base regarding intranasal steroid usage and steroid-induced glaucoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656479     DOI: 10.1007/s11882-009-0044-z

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  19 in total

1.  Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray.

Authors:  E J Schenkel; D P Skoner; E A Bronsky; S D Miller; D S Pearlman; A Rooklin; J P Rosen; M E Ruff; M L Vandewalker; A Wanderer; C V Damaraju; K B Nolop; B Mesarina-Wicki
Journal:  Pediatrics       Date:  2000-02       Impact factor: 7.124

2.  Present status of corticotropin; ACTH, cortisone, and hydrocortisone in ophthalmology.

Authors:  D M GORDON; J M MCLEAN; H KOTEEN
Journal:  Br J Ophthalmol       Date:  1953-02       Impact factor: 4.638

Review 3.  Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature.

Authors:  Relief Jones; Douglas J Rhee
Journal:  Curr Opin Ophthalmol       Date:  2006-04       Impact factor: 3.761

Review 4.  Corticosteroids and glaucoma risk.

Authors:  R C Tripathi; S K Parapuram; B J Tripathi; Y Zhong; K V Chalam
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

Review 5.  Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects.

Authors:  A Cave; P Arlett; E Lee
Journal:  Pharmacol Ther       Date:  1999-09       Impact factor: 12.310

6.  Discontinuing nasal steroids might lower intraocular pressure in glaucoma.

Authors:  Christina M Bui; Heidi Chen; Yu Shyr; Karen M Joos
Journal:  J Allergy Clin Immunol       Date:  2005-10-03       Impact factor: 10.793

7.  The heritable nature of dexamethasone-induced ocular hypertension.

Authors:  M F Armaly
Journal:  Arch Ophthalmol       Date:  1966-01

Review 8.  Assessment of intranasal corticosteroid use in allergic rhinitis: benefits, costs, and patient preferences.

Authors:  Leon Dupclay; Joseph Doyle
Journal:  Am J Manag Care       Date:  2002-09       Impact factor: 2.229

9.  Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells.

Authors:  A F Clark; K Wilson; M D McCartney; S T Miggans; M Kunkle; W Howe
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-01       Impact factor: 4.799

10.  Intraocular pressure elevation associated with inhalation and nasal corticosteroids.

Authors:  I Opatowsky; R M Feldman; R Gross; S T Feldman
Journal:  Ophthalmology       Date:  1995-02       Impact factor: 12.079

View more
  3 in total

1.  Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis.

Authors:  Carla V Valenzuela; James C Liu; Peter M Vila; Laura Simon; Michelle Doering; Judith E C Lieu
Journal:  Laryngoscope       Date:  2018-09-19       Impact factor: 3.325

2.  The effect of long-term use of intranasal steroids on intraocular pressure.

Authors:  Ali Şimşek; Cem Bayraktar; Sedat Doğan; Mehmet Karataş; Yasin Sarıkaya
Journal:  Clin Ophthalmol       Date:  2016-06-10

3.  Outcome of primary trabeculotomy ab interno (Trabectome) surgery in patients with steroid-induced glaucoma.

Authors:  Philip Ngai; Grace Kim; Garrick Chak; Ken Lin; Masahiro Maeda; Sameh Mosaed
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.